Todd Winge was appointed General Manager & Vice President of Manufacturing of the Kinsale site in June of 2019. Todd joined Lilly in 2008 as part of Lilly’s acquisition of ImClone. He has over 30 years of industry experience in the areas of clinical & commercial manufacturing operations, process development, engineering and supply chain management of monoclonal antibodies, small molecules and peptides. Prior to joining the Kinsale team, Todd held site head roles at Lilly’s monoclonal antibody manufacturing site in Branchburg, New Jersey and Lilly’s insulin manufacturing site in Indianapolis, Indiana.
Todd received his degree in Biomedical Engineering from Marquette University in Milwaukee, Wisconsin. Prior to joining Lilly, Todd worked in various roles at several leading U.S. biopharmaceutical companies and contract manufacturing organizations in California, Texas and North Carolina.
Mike Smith was appointed General Manager of the GBS centres in Cork, Kuala Lumpur and Mexico City in early 2019 having been with the company almost 20 years, enjoying a wide range of roles across the Finance function including assignments in Treasury, Manufacturing, Global Services and Affiliate. Part of the initial leadership team that established the GBS Cork Centre eight years ago, he then took up the role of CFO/Site Director for Eli Lilly Export SA in Geneva, Switzerland in 2011 before returning to GBS Cork in 2014.
Since then Mike has played a leading role in building capabilities outside of Finance to help partner and deliver services for Global HR, Medical, Customer Meeting Services, Global Transparency, and most recently the Clinical Development Organisation within Lilly. Mike is a qualified Chartered Accountant and completed his MBA at University College Cork.
Ashley Diaz-Granados was appointed as Managing Director of Eli Lilly and Company, Northern Europe in December 2018, having moved to the UK in early 2017 to lead Lilly Diabetes in Northern Europe. Ashley is passionate about great leadership, a mentor to numerous employees and an active diversity and inclusion advocate. Ashley has a bachelor’s degree in social work (Columbia); a Master’s degree in social work (Washington), and completed Harvard Business School’s Advanced Management programme.
Ashley has held a number of senior leadership roles at Lilly, including leading the US Integrated Health function, working to gain access in managed care organisations, pharmacy management companies, government programmes, physician practices and hospitals. Ashley’s prior career included leading a 150-strong sales team, Training and Development, and Six Sigma, where she became a certified black belt.